RNAimmune Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$27M
- Investors
-
7
RNAimmune General Information
Description
Developer of messenger ribonucleic acid-based therapeutics and vaccines designed to tackle indications in cancer, infectious, and rare diseases. The company leverages mRNA as a data carrier to instruct the human body to build responsive mechanisms against serious infectious diseases, enabling the medical industry to address unmet needs in the treatment of viral infections.
Contact Information
Website
www.rnaimmune.comCorporate Office
- 20511 Seneca Meadows Parkway
- Suite 260
- MD 20876
- United States
Corporate Office
- 20511 Seneca Meadows Parkway
- Suite 260
- MD 20876
- United States
RNAimmune Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 29-Mar-2022 | $27M | Completed | Clinical Trials - Phase 1 | ||
| 1. Seed Round | 21-Apr-2021 | Completed | Clinical Trials - Phase 1 |
RNAimmune Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
RNAimmune Comparisons
Industry
Financing
Details
RNAimmune Competitors (83)
One of RNAimmune’s 83 competitors is Allorion Therapeutics, a Venture Capital-Backed company based in Natick, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Allorion Therapeutics | Venture Capital-Backed | Natick, MA | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| etherna | Formerly VC-backed | Niel, Belgium | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| Cognition Therapeutics | Formerly VC-backed | New York, NY |
RNAimmune Patents
RNAimmune Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025081002-A1 | Ionizable lipids for the delivery of nucleic acids | Inactive | 11-Oct-2023 | ||
| WO-2025023949-A1 | Combination ras mrna cancer therapy | Inactive | 21-Jul-2023 | ||
| WO-2025024336-A1 | Compositions and methods of ribonucleic acid respiratory syncytial virus (rsv) vaccines | Inactive | 21-Jul-2023 | ||
| WO-2025024338-A2 | Ras mrna cancer vaccines and compositions and methods thereof | Inactive | 21-Jul-2023 | ||
| WO-2025024338-A3 | Ras mrna cancer vaccines and compositions and methods thereof | Inactive | 21-Jul-2023 | A61P35/00 |
RNAimmune Signals
RNAimmune Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shenzhen Qianhai Rotating Stone Fund Management | Growth/Expansion | Minority | ||
| High Forest | Venture Capital | Minority | ||
| Hong Kong Hongrun | Venture Capital | Minority | ||
| Shanghai Walga Biotechnology | Corporation | Minority | ||
| Sirnaomics | Corporation | Minority |
RNAimmune FAQs
-
When was RNAimmune founded?
RNAimmune was founded in 2020.
-
Where is RNAimmune headquartered?
RNAimmune is headquartered in MD.
-
What is the size of RNAimmune?
RNAimmune has 11 total employees.
-
What industry is RNAimmune in?
RNAimmune’s primary industry is Drug Discovery.
-
Is RNAimmune a private or public company?
RNAimmune is a Private company.
-
What is the current valuation of RNAimmune?
The current valuation of RNAimmune is .
-
What is RNAimmune’s current revenue?
The current revenue for RNAimmune is .
-
How much funding has RNAimmune raised over time?
RNAimmune has raised $37M.
-
Who are RNAimmune’s investors?
Shenzhen Qianhai Rotating Stone Fund Management, High Forest, Hong Kong Hongrun, Shanghai Walga Biotechnology, and Sirnaomics are 5 of 7 investors who have invested in RNAimmune.
-
Who are RNAimmune’s competitors?
Allorion Therapeutics, Inovio Pharmaceuticals, etherna, Sangamo Therapeutics, and Cognition Therapeutics are some of the 83 competitors of RNAimmune.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process